Vancomycin in the Target Site Treatment of Intracranial Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vancomycin, a novel intravenously administered antibiotic, currently plays a key role in the management of complicated multi-organism infections. However,current LC-MS/MS methods briefly describe parameters and the only reported internal standard was sometimes difficult to obtain. In our study,an updated LC-MS/MS method for the quantitative analysis of vancomycin in human serum was developed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Concentration Monitoring of Anti-infective Drugs in Human Cerebrospinal Fluid and Its Clinical Application

NCT06729619

Intracranial Infection Central Infection

ACTIVE_NOT_RECRUITING

Exploring Vancomycin Disposition in Neonates

NCT02096536

Neonatal Infection

RECRUITING PHASE4

Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin

NCT02443064

Blood Stream Infections Endocarditis MRSA

UNKNOWN PHASE4

Therapeutic Monitoring of Vancomycin in Critical Ill Patients: a Registry

NCT02896218

Critically Ill

UNKNOWN

Prevention of Neurosurgical Wound Infections

NCT00915967

Surgical Wound Infections

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vancomycin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vancomycin 1g q12h

Group Type EXPERIMENTAL

Vancomycin

Intervention Type DRUG

Vancomycin, a novel intravenously administered glycylcycline antibiotic, currently plays a key role in the management of complicated multi-organism infections.

Vancomycin 1g q8h

Group Type EXPERIMENTAL

Vancomycin

Intervention Type DRUG

Vancomycin, a novel intravenously administered glycylcycline antibiotic, currently plays a key role in the management of complicated multi-organism infections.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vancomycin

Vancomycin, a novel intravenously administered glycylcycline antibiotic, currently plays a key role in the management of complicated multi-organism infections.

Intervention Type DRUG